Ñî¹óåú´«Ã½Ò•îl

Cara M. squints and shields her eyes against the flood of hallway light, a blanket clutched at her chest, a vomit bag at the ready. She describes her migraine as an icepick stabbing through her right eye. At home, the glow from her laptop screen kicked off waves of nausea. Birdsongs landed like hammering spikes. For most of my ER career, I’d be examining Cara M. in a low-lighted, quiet-ish room. Not in today’s diluted version of health care. (Jay Baruch, 3/18)

I started taking a GLP-1 ten months ago. I’m still floored by the ways we are—and aren’t—talking about it. (Elizabeth Angell, 3/16)

The Food and Drug Administration recently signaled that it’s planning to let e-cigarette companies sell a broader range of flavors in the United States. It’s a welcome change, but the FDA isn’t going nearly far enough. (3/17)

Somewhere along the decade-plus in training, physicians are imbued with a damaging idea: that we can’t succeed anywhere outside of medicine. Keep your head down, we’re taught. Don’t ask too many questions. And the age-old line: You may not love your work anymore, but who else will hire you? In May 2025, after three years of full-time practice as an ENT surgeon, I left clinical medicine to find that out for myself. (Frances Mei Hardin, 3/18)

Until recently, if asked to profile a typical mass shooter, we would have described a middle-aged man who was socially isolated and in despair. Over the past several years, something has changed. We are witnessing the emergence of a different paradigm: a mass shooter no less despairing about life’s hardships but younger, highly connected to online social networks and seemingly convinced that in acting violently he or she is carrying out the only meaningful act possible in a world otherwise devoid of meaning. (James Densley and Jillian Peterson, 3/17)